• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例由大笑诱发的神经介导性晕厥经普萘洛尔和米多君联合治疗成功治愈。

A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.

作者信息

Amaki Makoto, Kamide Kei, Takiuchi Shin, Niizuma Shinichiro, Horio Takeshi, Kawano Yuhei

机构信息

Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan.

出版信息

Int Heart J. 2007 Jan;48(1):123-7. doi: 10.1536/ihj.48.123.

DOI:10.1536/ihj.48.123
PMID:17379987
Abstract

A 69-year-old man had been suffering from recurrent syncope induced by laughter since the age of 58. His syncope was reproduced by head-up tilt testing with isoproterenol infusion and we concluded that his laughter-induced syncope was one type of neurally mediated syndrome (NMS). His daughter also had NMS and her syncope was treated with propranolol. Propranolol and midodrine hydrochloride, an alpha(1)-adrenergic stimulant, were effective at preventing his laughter-induced syncope. This is a case report of laughter-induced syncope with a familial predisposition successfully treated with the combination of the nonselective beta-blocker propranolol and the alpha(1)-stimulator midodrine.

摘要

一名69岁男性自58岁起就一直患有因大笑诱发的反复晕厥。通过静脉输注异丙肾上腺素进行头高位倾斜试验可再现其晕厥症状,我们由此得出结论,他的大笑诱发的晕厥属于神经介导性综合征(NMS)的一种类型。他的女儿也患有NMS,其晕厥通过普萘洛尔进行了治疗。普萘洛尔和α1肾上腺素能兴奋剂盐酸米多君可有效预防他的大笑诱发的晕厥。本文报告了一例具有家族易感性的大笑诱发的晕厥病例,通过联合使用非选择性β受体阻滞剂普萘洛尔和α1兴奋剂米多君成功治愈。

相似文献

1
A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.一例由大笑诱发的神经介导性晕厥经普萘洛尔和米多君联合治疗成功治愈。
Int Heart J. 2007 Jan;48(1):123-7. doi: 10.1536/ihj.48.123.
2
Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.神经心源性晕厥两步治疗策略的前瞻性评估:米多君作为β受体阻滞剂难治性患者的二线治疗药物
Pacing Clin Electrophysiol. 1999 Feb;22(2):276-81. doi: 10.1111/j.1540-8159.1999.tb00439.x.
3
Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope.盐酸米多君对老年神经心源性晕厥患者安全有效。
J Am Geriatr Soc. 2010 Oct;58(10):2026-7. doi: 10.1111/j.1532-5415.2010.03069.x.
4
Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope.盐酸米多君治疗难治性血管迷走性晕厥患者的疗效与安全性。
Am J Cardiol. 2001 Jul 1;88(1):A7, 80-3. doi: 10.1016/s0002-9149(01)01594-6.
5
Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.米多君治疗神经介导性晕厥:一项双盲、随机、交叉研究。
Ann Neurol. 2002 Sep;52(3):342-5. doi: 10.1002/ana.10293.
6
[Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].阿替洛尔与米多君对血管迷走性晕厥患者的疗效及耐受性比较
Ter Arkh. 2006;78(4):64-8.
7
The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.盐酸米多君治疗儿童血管迷走性晕厥的疗效
J Pediatr. 2006 Dec;149(6):777-80. doi: 10.1016/j.jpeds.2006.07.031.
8
Midodrine: a role in the management of neurocardiogenic syncope.米多君:在神经心源性晕厥管理中的作用。
Heart. 1998 Jan;79(1):45-9. doi: 10.1136/hrt.79.1.45.
9
Possible involvement of cerebral hypoperfusion as trigger of neurally-mediated vasovagal syncope.
Pacing Clin Electrophysiol. 1998 Mar;21(3):613-6. doi: 10.1111/j.1540-8159.1998.tb00106.x.
10
Neurocardiogenic syncope: latest pharmacological therapies.神经心源性晕厥:最新药物治疗方法
Expert Opin Pharmacother. 2006 Jun;7(9):1151-62. doi: 10.1517/14656566.7.9.1151.

引用本文的文献

1
Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.笑和欢乐(趣味性、治疗性和有害性的系统研究):叙述性综合。
BMJ. 2013 Dec 12;347:f7274. doi: 10.1136/bmj.f7274.